COMPANY INTELLIGENCE PROFILE
Intas Pharmaceuticals Limited
pharmaceuticals
COMPANY OVERVIEW
About Intas Pharmaceuticals Limited
biosimilars development, recombinant proteins manufacturing, central nervous system, cardiodiabeto, plasma products, womens health, animal health, chronic therapies, pharmaceuticals, research & development, oncology, gastroenterology, urology, auto immune, rheumatology, nephrology, generic medicine, ndds products, hormone based therapies, pharmaceutical manufacturing, healthcare solutions, nanoaqualip technology, advanced drug delivery, biotech collaborations, generic drugs, global pharmaceutical company, clinical research, quality assurance, biosimilar development, patient care, drug innovation, quality standards, biosimilar pipeline, biotechnology, manufacturing facilities, product registration, biosimilar approvals, global markets, r&d innovation, product innovation, drug delivery platforms, healthcare, oncology drugs, new chemical entities, market expansion, biologics research, r&d infrastructure, parenteral formulations, customer engagement, api development, cardiology, biologics manufacturing, api synthesis, biologics development, biologics pipeline, formulation science, market presence, clinical trials, regulatory agencies, pharmaceutical development, complex generics, biologics, innovative drug delivery, services, market access, r&d investment, drug manufacturing, contract manufacturing, advanced formulations, global regulatory agencies, regulatory strategy, product pipeline, drug delivery technology, clinical validation, regulatory approval, complex formulations, drug delivery systems, patent filing, biosimilar market, regulatory approvals, clinical development, biosimilars, product licensing, patent strategy, regulatory compliance, api polymorphs, patent applications, generic formulation, biosimilar manufacturing, formulation development, b2b, drug delivery innovation, formulation technologies, parenteral products, pharmaceutical and medicine manufacturing, therapeutic areas, genetic therapies, injectables, plasma fractionation, drug formulations, venerable drugs, research and development, patented technologies, oral generics, complex dosage forms, pharmaceutical marketing, safety regulations, immunotherapy, registry portfolio, sustainable business model, market leadership, innovative research, neurodegenerative diseases, cns therapies, antibiotics, inhalation products, effervescent technology, rapid disintegration, hospital network focus, regional markets, exclusive licenses, advanced facility, global partnerships, telehealth expansion, manufacturing, distribution, medical, hospital & health care, health care, health, wellness & fitness, mechanical or industrial engineering
Company information
TECHNOLOGY INTELLIGENCE